Streetbeat News

Analyst Ratings

LSXMK

Morgan Stanley analyst Benjamin Swinburne has maintained an Equal-Weight rating on Liberty SiriusXM Gr (NASDAQ:LSXMK) but lowered the price target from $36 to $24.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 1:02 pm

VLN

Valens Semiconductor (NYSE:VLN) has received mostly bullish ratings from analysts in the last quarter, with a total of 4 bullish and 1 somewhat bullish ratings. The company has an average 12-month price target of $5.8, a decrease of 25.64% from the previous average price target of $7.80.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 1:01 pm

GMDA

Over the past 3 months, 4 analysts have published their opinion on Gamida Cell (NASDAQ:GMDA) stock, with 3 being bullish, 1 somewhat bullish, and none being bearish. The average price target is $7.25, representing a significant upside from the current price of $1.28. However, this average represents a 9.38% decrease from the previous average price target of $8.00.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 1:00 pm

SNPS

In the last quarter, Synopsys (NASDAQ:SNPS) received 8 bullish analyst ratings. The average price target for the stock is $467.5, indicating an upside from the current price of $434.85. This average has increased by 7.8% from the previous average price target of $433.67.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 1:00 pm

BTAI

BioXcel Therapeutics (NASDAQ:BTAI) has received 5 bullish and 3 indifferent analyst ratings in the last quarter. The average price target is $31.25, representing a significant upside from the current price of $4.33. However, this target is a 35.79% decrease from the previous average price target of $48.67.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 1:00 pm

IOBT

Morgan Stanley analyst Matthew Harrison maintains an Overweight rating on IO Biotech (NASDAQ:IOBT) but has lowered the price target from $11 to $7.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 1:00 pm

TSVT

In the last quarter, 2seventy bio (NASDAQ:TSVT) received 5 analyst ratings, with 1 being bullish, 3 somewhat bullish, and 1 indifferent. The average price target is $22.0, representing an upside from the current price of $6.03. However, this average price target is a 16.98% decrease from the previous average price target of $26.50.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 1:00 pm

TDG

TransDigm Gr (NYSE:TDG) has received mostly bullish ratings from analysts in the last quarter, with a total of 4 bullish, 3 somewhat bullish, and 2 indifferent ratings. The company's average price target is $981.67, which has increased by 8.59% over the past month.

Portfolio Pulse from Benzinga Insights

August 15, 2023 | 1:00 pm

IP

SMG

SXC

Three materials stocks with over 4% dividend yields have been highlighted by Wall Street's most accurate analysts. These include International Paper Company (IP), The Scotts Miracle-Gro Company (SMG), and SunCoke Energy, Inc. (SXC). Recent analyst ratings and price targets for these stocks have been provided, along with their recent financial performance.

Portfolio Pulse from Lisa Levin

August 15, 2023 | 1:00 pm

DH

Morgan Stanley analyst Craig Hettenbach has maintained an Overweight rating on Definitive Healthcare (NASDAQ:DH), but lowered the price target from $17 to $15.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 12:59 pm